Navigation Links
Boston Biotech R&D Conference to Showcase Next-Generation Newsmakers and Massachusetts as Leader in Biotech Discovery

Oct. 27 Event Kicks Off With Keynote by Investor and New England Patriots President Jonathan Kraft

Boston, MA (Vocus) September 30, 2009 -- The Boston biotechnology industry will get an early look at biotech's future value-drivers and newsmakers at the 2009 Boston Biotech R&D Conference on October 27, 2009 at Harvard Medical School.

At the one-day event, recently funded companies will present their science and platforms for the first time to a limited audience of 100 venture capitalists and pharmaceutical executives. The second annual conference will open with a keynote address by Jonathan Kraft, president of the New England Patriots, and president and chief executive officer of The Kraft Group, a group of privately held companies in professional sports, manufacturing and real estate investment.

"This will be an important gathering of the brightest minds in Boston's biotech research and development to shine a spotlight on their novel science and technology platforms," said Christoph Westphal, M.D., Ph.D., chief executive officer of Sirtris, a GSK company and senior vice president of the Center of Excellence for External Drug Discovery (CEEDD), GSK. "Thanks to the success of last year's inaugural R&D Conference, we received interest from biotech companies from across the country to participate in this year's conference, which reinforces Massachusetts' standing in the industry on a global scale."

Westphal founded the Boston Biotech Conference series four years ago, which includes the annual Boston Biotech Business Development Conference in April and Boston Biotech CEO Conference in June. In its second year, the R&D Conference is designed to showcase the next generation of leading biotech and pharmaceutical companies from the Boston area.

According to conference sponsor MassBio, the state continues to be a leader in the nation's biotech industry. With the number of Massachusetts residents working in the biotech industry at an all time high, companies in the state account for 6.4 percent of drugs in the pipeline globally, and next to California, Massachusetts is the best funded state for biotech venture capital investment.
"The Boston Biotech Conference series is one of the highlights of the year for our industry, as it offers an early look at the regional R&D success stories we are likely to read about in the upcoming year," said President & CEO of MassBio Robert K. Coughlin. "It's gatherings like these that help to spur the innovation and investment, which makes Massachusetts' biotechnology industry a global leader."

The 2009 Boston Biotech R&D Conference will highlight up-and-coming biotech companies in the Boston area. The agenda features several luminaries in medicine and research, as well as executives of the next generation of leading biotech and pharma companies from the Boston area. Jonathan Kraft president and chief executive officer of The Kraft Group and president of the New England Patriots, will provide the keynote address. The conference is being organized by Christoph Westphal, M.D., Ph.D., Chief Executive Officer of Sirtris, a GSK company and Senior Vice President of the Center of Excellence for External Drug Discovery (CEEDD), GSK and Michelle Dipp, M.D., Ph.D., Vice President, Head of U.S. CEEDD, GSK. The conference is sponsored by Alexandria Real Estate Equities, Clinquest, MassBio, Massachusetts Life Sciences Center, Merriman Curhan Ford & Co. and Pure Communications, Inc. For more information or to register for the conference, visit


Read the full story at

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related biology technology :

1. Boston Scientific to Explore Sale of Cardiac Surgery and Vascular Surgery Businesses
2. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
3. Boston Scientific Amends Credit Facility and Prepays $1 Billion on Loan
4. Boston Scientific to Participate in the Bear Stearns 20th Annual Healthcare Conference
5. Revolutionary Genomics Research Group Opens Boston Office; Provides DNA Evidence in Workers Comp Cases
6. Boston Scientific Announces Election of Ray Elliott to Its Board of Directors
7. Alliance for Medical Devices, Instrumentation and Diagnostics formed between Fraunhofer Center for Manufacturing Innovation and Boston University
8. Boston Scientific Releases Remote Monitoring Data from its Wireless LATITUDE(R) Patient Management System
9. Genzyme Begins Major Expansion of Boston Manufacturing Facility
10. New Scientists Boost Disease-based Research at Boston Biomedical Research Institute
11. Boston Scientific to Webcast Conference Call Discussing Third Quarter Financial Results
Post Your Comments:
(Date:11/24/2015)... , ... November 24, 2015 , ... The Academy of ... Interest Group (SIG), MultiGP, also known as Multirotor Grand Prix, to represent the First–Person ... few years. Many AMA members have embraced this type of racing and several new ...
(Date:11/24/2015)... Israel , Nov. 24, 2015  Tikcro Technologies Ltd. (OTCQB: TIKRF) ... on December 29, 2015 at 11:00 a.m. Israel ... Electra Tower, 98 Yigal Allon Street, 36 th Floor, ... of Eric Paneth and Izhak Tamir to the ... Rami Skaliter as external directors; , approval of an amendment to ...
(Date:11/24/2015)... , ... November 24, 2015 , ... ... the environment are paramount. Insertion points for in-line sensors can represent a weak ... the InTrac 781/784 series of retractable sensor housings , which are designed ...
(Date:11/24/2015)... /CNW Telbec/ - ProMetic Life Sciences Inc. (TSX: PLI) (OTCQX: ... Pierre Laurin , President and Chief Executive Officer of ProMetic, ... Jaffray 27 th Annual Healthcare Conference to be held ... st , at 8.50am (ET) and ProMetic,s ... day. The presentation will be available live via a webcast ...
Breaking Biology Technology:
(Date:11/12/2015)... 11, 2015   Growing need for low-cost, ... has been paving the way for use of ... discrete analytes in clinical, agricultural, environmental, food and ... used in medical applications, however, their adoption is ... to continuous emphasis on improving product quality and ...
(Date:11/10/2015)...  In this report, the biomarkers market ... type, application, disease indication, and geography. The ... consumables, services, software. The type segments included ... biomarkers, and validation biomarkers. The applications segments ... drug discovery and development, personalized medicine, disease ...
(Date:11/9/2015)... DUBLIN , Nov. 09, 2015 /PRNewswire/ ... announced the addition of the "Global ... to their offering. --> ... "Global Law Enforcement Biometrics Market 2015-2019" ... Research and Markets ( ) ...
Breaking Biology News(10 mins):